THE IMPORTANCE OF NEF IN THE INDUCTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION FROM PRIMARY QUIESCENT CD4 LYMPHOCYTES

被引:375
|
作者
SPINA, CA
KWOH, TJ
CHOWERS, MY
GUATELLI, JC
RICHMAN, DD
机构
[1] UNIV CALIF SAN DIEGO,DEPT MED,LA JOLLA,CA 92093
[2] VET AFFAIRS MED CTR,DIV INFECT DIS,SAN DIEGO,CA 92161
[3] BAXTER DIAGNOST,LIFE SCI RES LAB,SAN DIEGO,CA 92121
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1994年 / 179卷 / 01期
关键词
D O I
10.1084/jem.179.1.115
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The viral regulatory gene, nef, is unique to the human immunodeficiency viruses (HIV) and their related primate lentiviruses. Expression of the nef gene has been shown to be essential to the maintenance of high levels of virus replication and the development of pathogenesis in the animal model of simian immunodeficiency virus (SIV) infection. In contrast to this in vivo model, the use of standard T cell culture systems to study nef function in vitro has produced a spectrum of contradictory results, and has failed to demonstrate a significant positive influence of nef on viral life cycle. We have developed a cell model to study regulation of HIV-1 replication that we believe reflects more accurately virus-cell interactions as they occur in vivo. Our experimental system used acute virus infection of purified, quiescent CD4 lymphocytes and subsequent induction of viral replication through T cell activation. With this cell model, NL4-3 virus clones with open and mutated nef reading frames were compared for replication competence. The clones with nef mutations showed reproducible and significant reductions in both rates of growth and maximal titers achieved. The degree of reduced replication was dependent on initial virus inoculum and the timing of T cell activation. The influence of nef was highly significant for induction of virus replication from a latent state within resting CD4 cells. Its effect was less apparent for virus infection of fully proliferating CD4 cells. This study demonstrates that nef confers a positive growth advantage to HIV-1 that becomes readily discernable in the primary cell setting of virus induction through T cell activation. The experimental cell model, which we describe here, provides not only a means to study nef function in vitro, but also provides important clues to the function of nef in HIV infection in vivo.
引用
收藏
页码:115 / 123
页数:9
相关论文
共 50 条
  • [21] THE NEGATIVE EFFECT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF ON CELL-SURFACE CD4 EXPRESSION IS NOT SPECIES-SPECIFIC AND REQUIRES THE CYTOPLASMIC DOMAIN OF CD4
    GARCIA, JV
    ALFANO, J
    MILLER, AD
    JOURNAL OF VIROLOGY, 1993, 67 (03) : 1511 - 1516
  • [22] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF ASSOCIATES WITH A CELLULAR SERINE KINASE IN T-LYMPHOCYTES
    SAWAI, ET
    BAUR, A
    STRUBLE, H
    PETERLIN, BM
    LEVY, JA
    CHENGMAYER, C
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (04) : 1539 - 1543
  • [23] Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytes
    Zhang, X
    Gaubin, M
    Briant, L
    Srikantan, V
    Murali, R
    Saragovi, U
    Weiner, D
    Devaux, C
    Autiero, M
    PiatierTonneau, D
    Greene, MI
    NATURE BIOTECHNOLOGY, 1997, 15 (02) : 150 - 154
  • [24] Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytes
    Xin Zhang
    Muriel Gaubin
    Laurence Briant
    Vasantha Srikantan
    Ramachandran Murali
    Uri Saragovi
    David Weiner
    Christian Devaux
    Monica Autiero
    Dominique Piatier-Tonneau
    Mark I. Greene
    Nature Biotechnology, 1997, 15 : 150 - 154
  • [25] OLTIPRAZ, AN INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION
    PROCHASKA, HJ
    YEH, Y
    BARON, P
    POLSKY, B
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (09) : 3953 - 3957
  • [26] ANTIVIRAL STRATEGIES IN THE REPLICATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    WAINBERG, MA
    BOUR, S
    GELEZIUNAS, R
    BENTWICH, Z
    UNION MEDICALE DU CANADA, 1992, 121 (05): : 307 - &
  • [27] THALIDOMIDE INHIBITS THE REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    MAKONKAWKEYOON, S
    LIMSONPOBRE, RNR
    MOREIRA, AL
    SCHAUF, V
    KAPLAN, G
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (13) : 5974 - 5978
  • [28] MACROPHAGE-TROPIC STRAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 UTILIZE THE CD4 RECEPTOR
    COLLMAN, R
    GODFREY, B
    CUTILLI, J
    RHODES, A
    HASSAN, NF
    SWEET, R
    DOUGLAS, SD
    FRIEDMAN, H
    NATHANSON, N
    GONZALEZSCARANO, F
    JOURNAL OF VIROLOGY, 1990, 64 (09) : 4468 - 4476
  • [29] MAPPING GENETIC-DETERMINANTS FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RESISTANCE TO SOLUBLE CD4
    OBRIEN, WA
    CHEN, ISY
    HO, DD
    DAAR, ES
    JOURNAL OF VIROLOGY, 1992, 66 (05) : 3125 - 3130
  • [30] CD4 IS RETAINED IN THE ENDOPLASMIC-RETICULUM BY THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GLYCOPROTEIN PRECURSOR
    CRISE, B
    BUONOCORE, L
    ROSE, JK
    JOURNAL OF VIROLOGY, 1990, 64 (11) : 5585 - 5593